0001681648-16-000001.txt : 20160809 0001681648-16-000001.hdr.sgml : 20160809 20160809143209 ACCESSION NUMBER: 0001681648-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160809 DATE AS OF CHANGE: 20160809 EFFECTIVENESS DATE: 20160809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Providence Therapeutics Inc. CENTRAL INDEX KEY: 0001681648 IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-268573 FILM NUMBER: 161817353 BUSINESS ADDRESS: STREET 1: 140 SUNHAVEN CLOSE SE CITY: CALGARY STATE: A0 ZIP: T2X 2V9 BUSINESS PHONE: 403-909-4532 MAIL ADDRESS: STREET 1: 140 SUNHAVEN CLOSE SE CITY: CALGARY STATE: A0 ZIP: T2X 2V9 D 1 primary_doc.xml X0707 D LIVE 0001681648 Providence Therapeutics Inc. 140 SUNHAVEN CLOSE SE CALGARY A0 ALBERTA, CANADA T2X 2V9 403-909-4532 ALBERTA, CANADA None None Corporation true 2015 Bradley Thomas Sorenson 140 Sunhaven Close SE Calgary A0 ALBERTA, CANADA T2X 2V9 Executive Officer Director Nicholas M. Dean 2110 Whisper Wind Lane Encinitas CA CALIFORNIA 92024 Executive Officer Director Eric Gates Marcusson 239 Brannan Street, #8J San Francisco CA CALIFORNIA 94107 Executive Officer Pharmaceuticals No Revenues 06b false 2016-02-03 false true true false 0 1486550 1396550 90000 All amounts are in Canadian dollars. A $90,000 investment was rescinded shortly after offer made. true 9 25 0 0 0 false Providence Therapeutics Inc. /s/Bradley Sorenson Bradley Sorenson President and CEO 2016-08-03